Dyspnoea perception during clinical remission of atopic asthma Source: Eur Respir J 2002; 19: 1047-1050 Year: 2002
Factors associated with remission of atopic asthma in adults Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses Year: 2019
Cough sensitivity changes in allergic rhinitis and atopic dermatitis without clinical symptoms from lower airways Source: Eur Respir J 2002; 20: Suppl. 38, 188s Year: 2002
Patients’ perception of allergic asthma and their compliance to omalizumab in an Italian clinical setting Source: International Congress 2017 – Asthma management Year: 2017
Subjects in clinical remission of atopic asthma show normal dyspnoea perception during methacholine and adenosine induced bronchoconstriction Source: Eur Respir J 2001; 18: Suppl. 33, 46s Year: 2001
Quality of life in school children with atopic asthma and allergic rhinitis Source: Eur Respir J 2006; 28: Suppl. 50, 852s Year: 2006
Treatment and outcomes in patients with asthma and allergic rhinitis Source: Eur Respir J 2005; 26: Suppl. 49, 576s Year: 2005
Incidence and remission of asthma and allergic rhinitis in Italy Source: Annual Congress 2010 - New insights in the epidemiology of asthma Year: 2010
Quality of life, clinical symptoms and nasal obstruction in patients with allergic rhinitis Source: Eur Respir J 2003; 22: Suppl. 45, 418s Year: 2003
Dupilumab improves patient-reported outcomes in uncontrolled persistent asthma patients with ongoing allergic rhinitis Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017
The evaluations of allergic rhinitis symptoms in patients with asthma and allergic rhinitis with the addiing of montelukast in asthma treatment Source: Eur Respir J 2004; 24: Suppl. 48, 124s Year: 2004
Is wheezing the most common symptom of asthma exacerbation in children? Source: Annual Congress 2008 - Exercise-induced asthma, acute severe asthma and allergic rhinitis in children Year: 2008
Improved symptom relief with omalizumab in the treatment of allergic rhinitis Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009
Improvements in asthma control and quality of life with omalizumab in allergic (IgE-mediated) asthma patients Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma Year: 2012
Clinical relevance of anti-inflammatory treatment of rhinitis for the course and prognosis of allergic bronchial asthma Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control Year: 2007
Effectiveness of omalizumab in improving quality of life in patients with ‘steroid-resistant‘ asthma and severe allergic rhinitis Source: Annual Congress 2012 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2012
Mood disturbances manifestation in asthma and allergic rhinitis Source: Eur Respir J 2006; 28: Suppl. 50, 231s Year: 2006
Predictors for asthma onset from cough variant asthma Source: Eur Respir J 2002; 20: Suppl. 38, 409s Year: 2002
Quality of life in children with asthma associated with allergic rhinitis Source: Annual Congress 2009 - How viruses, allergic rhinitis and air pollution affect childhood asthma Year: 2009
Predictors of work-related sensitisation, allergic rhinitis and asthma in early work life Source: Eur Respir J 2014; 44: 657-665 Year: 2014